| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5689383 | European Urology | 2016 | 9 Pages |
Abstract
Genomic classifier and two clinico-pathologic risk models were evaluated on their ability to predict metastases among men receiving salvage radiation therapy for recurrent prostate cancer. Genomic classifier was able to identify candidates for further therapies due to their very high-risk of metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Stephen J. Freedland, Voleak Choeurng, Lauren Howard, Amanda De Hoedt, Marguerite du Plessis, Kasra Yousefi, Lucia L. Lam, Christine Buerki, Seong Ra, Bruce Robbins, Edouard J. Trabulsi, Nikhil L. Shah, Firas Abdollah, Felix Y. Feng, Elai Davicioni,